Hospitals Stocks in India
Hospitals: Apollo Hospitals Enterprise Ltd owns the largest revenue base; Narayana Hrudayalaya Ltd has the fastest current growth.
Nifty Hospitals Index — Constituents & Performance
The Hospitals companies below are the listed Indian Hospitals universe this page tracks — the same constituent set people search for as the Nifty Hospitals index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.
How has Hospitals moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 48% ahead of NIFTY 500. Earnings across its companies grew 14% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 17 weeks running.
RS ↑17w · 16/19 >200d (+0) · 12/19 lead (−4) · EPS 14/19↑
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 19 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Is Hospitals outperforming NIFTY 500?
Hospitals has outperformed NIFTY 500 by 7.8% over the last 52 weeks. Over 13 weeks the gap is a lead of 10.2%. 16 of 19 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Sakar Healthcare Ltd is the strongest against the sector itself at +57%. Readings are as of 2026-07-19.
Sector metric: 17.6 as of 2026-07-19 · NARROWING · rising.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Hospitals has outperformed NIFTY 500 by 7.8% over 52 weeks and 10.2% over 13 weeks. 16 of 19 covered companies beat NIFTY on Mansfield relative strength, while 9 of 19 beat the sector itself. Apollo Hospitals Enterprise Ltd leads with revenue of ₹25,229 crore, based on 19 of 19 comparable companies through Mar 2026.
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1KMC Speciality Hospitals (India) Ltd524520 | 82.1/100Sector-leading setup78% evidence | LEADER | 30.8/35 Revenue 32.5% · PAT 100% · OPM change 6 pp 83% evidence | 20.6/25 ROCE 26% · OPM 31% 76% evidence | 11.2/20 P/E 44.5× · PEG — 50% evidence | 19.5/20 RS sector 34% · RS bench 44.3% · 1Y 97.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.8 + 20.6 + 11.2 + 19.5 = 82.1 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Artemis Medicare Services LtdARTEMISMED | 67.9/100Favorable setup96% evidence | LEADER | 24.4/35 Revenue 15.5% · PAT 24.1% · OPM change 3 pp 88% evidence | 12.0/25 ROCE 14.6% · OPM 18% 100% evidence | 14.4/20 P/E 44.6× · PEG 1.09 100% evidence | 17.1/20 RS sector 8.2% · RS bench 17.1% · 1Y 24.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 12 + 14.4 + 17.1 = 67.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Sakar Healthcare LtdSAKAR | 67.6/100Favorable setup87% evidence | LEADER | 32.2/35 Revenue 43.9% · PAT 71.4% · OPM change 5 pp 95% evidence | 11.0/25 ROCE 12.7% · OPM 29% 95% evidence | 6.9/20 P/E 54.6× · PEG — 50% evidence | 17.5/20 RS sector 57% · RS bench 68.5% · 1Y 144.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 32.2 + 11 + 6.9 + 17.5 = 67.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Apollo Hospitals Enterprise LtdAPOLLOHOSP | 67.1/100Favorable setup78% evidence | LEADER | 23.6/35 Revenue 15.8% · PAT 33% · OPM change 1 pp 83% evidence | 15.4/25 ROCE 17.9% · OPM 15% 76% evidence | 12.6/20 P/E 65.8× · PEG — 50% evidence | 15.5/20 RS sector 5.2% · RS bench 13.7% · 1Y 19.9%8 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 15.4 + 12.6 + 15.5 = 67.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Rainbow Childrens Medicare LtdRAINBOW | 58.0/100Mixed-positive evidence100% evidence | BREAKING OUT | 18.0/35 Revenue 18.3% · PAT 12.4% · OPM change 0 pp 100% evidence | 17.1/25 ROCE 17.4% · OPM 29% 100% evidence | 7.3/20 P/E 54.1× · PEG 2.97 100% evidence | 15.6/20 RS sector 4% · RS bench 12.4% · 1Y -2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 17.1 + 7.3 + 15.6 = 58 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Max Healthcare Institute LtdMAXHEALTH | 57.8/100Mixed-positive evidence90% evidence | TURNING | 25.1/35 Revenue 19.1% · PAT 34% · OPM change 1 pp 88% evidence | 15.8/25 ROCE 14.7% · OPM 28% 100% evidence | 10.8/20 P/E 72.1× · PEG 1.73 100% evidence | 6.1/20 RS sector -7.9% · RS bench 0.1% · 1Y -14.2%2 of 10 weeks ahead 70% evidence |
| Exact sum: 25.1 + 15.8 + 10.8 + 6.1 = 57.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.9% and the one-year return is -14.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 7Kovai Medical Center & Hospital LtdKOVAI | 54.6/100Mixed-positive evidence96% evidence | FADING | 17.8/35 Revenue 15.8% · PAT 16.2% · OPM change -1 pp 88% evidence | 21.3/25 ROCE 22.6% · OPM 27% 100% evidence | 10.4/20 P/E 26.3× · PEG 1.51 100% evidence | 5.1/20 RS sector -7.4% · RS bench 0.2% · 1Y -3.3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.8 + 21.3 + 10.4 + 5.1 = 54.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Dr Agarwals Eye Hospital LtdDRAGARWQ | 54.3/100Mixed-positive evidence90% evidence | ASLEEP | 19.6/35 Revenue 18.6% · PAT 27.8% · OPM change -4 pp 88% evidence | 16.8/25 ROCE 17.4% · OPM 28% 100% evidence | 10.6/20 P/E 34.6× · PEG 1.72 100% evidence | 7.3/20 RS sector -4% · RS bench -1% · 1Y 13.4%4 of 7 weeks ahead 70% evidence |
| Exact sum: 19.6 + 16.8 + 10.6 + 7.3 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Global Health LtdMEDANTA | 54.1/100Mixed-positive evidence100% evidence | LEADER | 12.3/35 Revenue 21.3% · PAT 3.4% · OPM change -2 pp 100% evidence | 13.9/25 ROCE 17.1% · OPM 22% 100% evidence | 11.3/20 P/E 66× · PEG 1.11 100% evidence | 16.6/20 RS sector 4.5% · RS bench 13% · 1Y 6.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 12.3 + 13.9 + 11.3 + 16.6 = 54.1 · Decision use: Price leads the evidence: RS versus the benchmark is 13%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10Indraprastha Medical Corporation LtdINDRAMEDCO | 52.2/100Mixed-positive evidence90% evidence | ASLEEP | 12.4/35 Revenue 9.3% · PAT 13.7% · OPM change -1 pp 88% evidence | 18.6/25 ROCE 35.8% · OPM 17% 100% evidence | 17.2/20 P/E 18.3× · PEG 0.92 100% evidence | 4.0/20 RS sector -8.4% · RS bench -17.3% · 1Y -20.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.4 + 18.6 + 17.2 + 4 = 52.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11Fortis Healthcare LtdFORTIS | 50.2/100Mixed-positive evidence78% evidence | FADING | 23.6/35 Revenue 17.3% · PAT 31.5% · OPM change 1 pp 83% evidence | 12.8/25 ROCE 13.4% · OPM 23% 76% evidence | 9.0/20 P/E 67.5× · PEG — 50% evidence | 4.8/20 RS sector -7.3% · RS bench 0.2% · 1Y 11.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 12.8 + 9 + 4.8 = 50.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.3% and the one-year return is 11.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Yatharth Hospital & Trauma Care Services LtdYATHARTH | 48.2/100Mixed-negative evidence78% evidence | FADING | 19.5/35 Revenue 36.1% · PAT 31.5% · OPM change -2 pp 83% evidence | 11.7/25 ROCE 12.4% · OPM 23% 76% evidence | 8.8/20 P/E 45× · PEG — 50% evidence | 8.2/20 RS sector 0.2% · RS bench 8.1% · 1Y 30.6%11 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 11.7 + 8.8 + 8.2 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13GPT Healthcare LtdGPTHEALTH | 47.9/100Mixed-negative evidence70% evidence | TURNING | 10.3/35 Revenue 16% · PAT -14% · OPM change -2 pp 83% evidence | 18.5/25 ROCE 19.9% · OPM 18% 95% evidence | 11.2/20 P/E 32.5× · PEG — 15% evidence | 7.9/20 RS sector -15.8% · RS bench 17.9% · 1Y 5.9%10 of 10 weeks ahead 70% evidence |
| Exact sum: 10.3 + 18.5 + 11.2 + 7.9 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Aster DM Quality Care LtdASTERDM | 39.4/100Mixed-negative evidence96% evidence | LEADER | 12.6/35 Revenue 12.2% · PAT -80% · OPM change 1 pp 88% evidence | 9.8/25 ROCE 11.4% · OPM 19% 100% evidence | 1.5/20 P/E 176× · PEG 3.07 100% evidence | 15.5/20 RS sector 10.8% · RS bench 19.6% · 1Y 41.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 9.8 + 1.5 + 15.5 = 39.4 · Decision use: Price leads the evidence: RS versus the benchmark is 19.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Krishna Institute of Medical Sciences LtdKIMS | 39.4/100Mixed-negative evidence78% evidence | LEADER | 10.4/35 Revenue 28.7% · PAT -41.5% · OPM change -6 pp 83% evidence | 9.2/25 ROCE 9.3% · OPM 19% 76% evidence | 5.5/20 P/E 136× · PEG — 50% evidence | 14.3/20 RS sector 3.7% · RS bench 12% · 1Y 5.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 10.4 + 9.2 + 5.5 + 14.3 = 39.4 · Decision use: Price leads the evidence: RS versus the benchmark is 12%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Narayana Hrudayalaya LtdNH | 39.3/100Mixed-negative evidence87% evidence | TURNING | 12.6/35 Revenue 59.6% · PAT 3.8% · OPM change -5 pp 100% evidence | 11.6/25 ROCE 15.5% · OPM 17% 100% evidence | 6.1/20 P/E 48.1× · PEG 3 65% evidence | 9.0/20 RS sector -4.3% · RS bench 9.2% · 1Y 1.9%5 of 10 weeks ahead 70% evidence |
| Exact sum: 12.6 + 11.6 + 6.1 + 9 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Healthcare Global Enterprises LtdHCG | 35.9/100Mixed-negative evidence65% evidence | TURNING | 13.1/35 Revenue 14.5% · PAT -53.4% · OPM change 1.1 pp 83% evidence | 7.4/25 ROCE 8.3% · OPM 19.2% 76% evidence | 8.5/20 P/E 349× · PEG — 15% evidence | 6.9/20 RS sector -8.1% · RS bench 3.4% · 1Y 18.5%8 of 10 weeks ahead 70% evidence |
| Exact sum: 13.1 + 7.4 + 8.5 + 6.9 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Shalby LtdSHALBY | 30.7/100Adverse evidence69% evidence | ASLEEP | 15.6/35 Revenue 4.8% · PAT 100% · OPM change 2 pp 62% evidence | 2.5/25 ROCE 6.5% · OPM 10% 95% evidence | 9.1/20 P/E 46.6× · PEG — 50% evidence | 3.5/20 RS sector -28.4% · RS bench -14.9% · 1Y -22.3%6 of 10 weeks ahead 70% evidence |
| Exact sum: 15.6 + 2.5 + 9.1 + 3.5 = 30.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Jupiter Life Line Hospitals LtdJLHL | 29.8/100Adverse evidence100% evidence | BASING | 8.4/35 Revenue 14.7% · PAT -3.1% · OPM change -3 pp 100% evidence | 10.5/25 ROCE 14.8% · OPM 19% 100% evidence | 6.4/20 P/E 56.9× · PEG 3.44 100% evidence | 4.5/20 RS sector -74.8% · RS bench 17.9% · 1Y -77.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 8.4 + 10.5 + 6.4 + 4.5 = 29.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Market action
Sakar Healthcare Ltd has the strongest one-year price move in Hospitals at +144.1%. It also leads on Mansfield relative strength against NIFTY at +68.5%. 16 of 19 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-31.
Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Hospitals itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
Revenue Scale & Growth Durability
Apollo Hospitals Enterprise Ltd has the highest Revenue among the 19 Hospitals companies compared here, at ₹25,229 crore. Fortis Healthcare Ltd is next at ₹9,128 crore. Narayana Hrudayalaya Ltd has the highest Revenue growth at 59.6%, so level and change sit with different companies. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Apollo Hospitals Enterprise Ltd is the scale leader at ₹25,229 crore, 176.4% ahead of Fortis Healthcare Ltd. Narayana Hrudayalaya Ltd's growth is 59.6% from a ₹9,073 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: Apollo Hospitals Enterprise Ltd is the scale benchmark; Narayana Hrudayalaya Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Apollo Hospitals Enterprise Ltd's growth falls below Narayana Hrudayalaya Ltd's for two consecutive comparable reports while operating margin also compresses.
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd APOLLOHOSP | ₹6.6K Cr | 18% | Mar 2026 |
| Narayana Hrudayalaya Ltd NH | ₹2.7K Cr | 78% | Jun 2026 |
| Fortis Healthcare Ltd FORTIS | ₹2.4K Cr | 18% | Mar 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | ₹2.1K Cr | 12% | Mar 2026 |
| Global Health Ltd MEDANTA | ₹1.3K Cr | 26% | Jun 2026 |
| Aster DM Quality Care Ltd ASTERDM | ₹1.2K Cr | 18% | Mar 2026 |
| Krishna Institute of Medical Sciences Ltd KIMS | ₹1.1K Cr | 35% | Mar 2026 |
| Healthcare Global Enterprises Ltd HCG | ₹652 Cr | 11% | Mar 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | ₹470 Cr | 33% | Jun 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | ₹414 Cr | 16% | Mar 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | ₹411 Cr | 16% | Jun 2026 |
| Indraprastha Medical Corporation Ltd INDRAMEDCO | ₹365 Cr | 9.3% | Mar 2026 |
| Yatharth Hospital & Trauma Care Services Ltd YATHARTH | ₹342 Cr | 47% | Mar 2026 |
| Shalby Ltd SHALBY⚠ unverified | ₹287 Cr | 8.3% | Mar 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | ₹279 Cr | 16% | Mar 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | ₹126 Cr | 25% | Mar 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | ₹120 Cr | 20% | Mar 2026 |
| KMC Speciality Hospitals (India) Ltd 524520 | ₹82 Cr | 34% | Mar 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | ₹73 Cr | 38% | Jun 2026 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
Revenue growth · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
Operating Economics & Margin Trend
KMC Speciality Hospitals (India) Ltd has the highest OPM among the 19 Hospitals companies compared here, at 31%. Rainbow Childrens Medicare Ltd is next at 29%. The same company also holds the highest Margin change, at +6 percentage points. 19 of 19 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: KMC Speciality Hospitals (India) Ltd leads both opm at 31% and margin change at +6 percentage points.
Investor read: KMC Speciality Hospitals (India) Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| KMC Speciality Hospitals (India) Ltd 524520 | 31% | +6.0 pp | Mar 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | 29% | 0.0 pp | Jun 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | 29% | +5.0 pp | Jun 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | 28% | +1.0 pp | Mar 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | 28% | −4.0 pp | Mar 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | 27% | −1.0 pp | Mar 2026 |
| Fortis Healthcare Ltd FORTIS | 23% | +1.0 pp | Mar 2026 |
| Yatharth Hospital & Trauma Care Services Ltd YATHARTH | 23% | −2.0 pp | Mar 2026 |
| Global Health Ltd MEDANTA | 22% | −2.0 pp | Jun 2026 |
| Healthcare Global Enterprises Ltd HCG | 19% | +1.1 pp | Mar 2026 |
| Aster DM Quality Care Ltd ASTERDM | 19% | +1.0 pp | Mar 2026 |
| Krishna Institute of Medical Sciences Ltd KIMS | 19% | −6.0 pp | Mar 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | 19% | −3.0 pp | Jun 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | 18% | +3.0 pp | Mar 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | 18% | −2.0 pp | Mar 2026 |
| Narayana Hrudayalaya Ltd NH | 17% | −5.0 pp | Jun 2026 |
| Indraprastha Medical Corporation Ltd INDRAMEDCO | 17% | −1.0 pp | Mar 2026 |
| Apollo Hospitals Enterprise Ltd APOLLOHOSP | 15% | +1.0 pp | Mar 2026 |
| Shalby Ltd SHALBY⚠ unverified | 10% | +2.0 pp | Mar 2026 |
Full 20-quarter history · every available company
OPM · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
Margin change · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
Profit Scale & Acceleration
Apollo Hospitals Enterprise Ltd has the highest Net profit among the 19 Hospitals companies compared here, at ₹2,002 crore. Max Healthcare Institute Ltd is next at ₹1,442 crore. KMC Speciality Hospitals (India) Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: Apollo Hospitals Enterprise Ltd leads with ₹2,002 crore of TTM profit, 38.8% above Max Healthcare Institute Ltd. KMC Speciality Hospitals (India) Ltd shows ≥100% on the scoring scale (108.7% uncapped) growth from a ₹48 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Apollo Hospitals Enterprise Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd APOLLOHOSP | ₹551 Cr | 33% | Mar 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | ₹342 Cr | 7.2% | Mar 2026 |
| Fortis Healthcare Ltd FORTIS | ₹271 Cr | 44% | Mar 2026 |
| Narayana Hrudayalaya Ltd NH | ₹207 Cr | 5.1% | Jun 2026 |
| Global Health Ltd MEDANTA | ₹157 Cr | -1.3% | Jun 2026 |
| Aster DM Quality Care Ltd ASTERDM | ₹154 Cr | 79% | Mar 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | ₹63 Cr | 17% | Jun 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | ₹63 Cr | 15% | Mar 2026 |
| Yatharth Hospital & Trauma Care Services Ltd YATHARTH | ₹45 Cr | 15% | Mar 2026 |
| Indraprastha Medical Corporation Ltd INDRAMEDCO | ₹42 Cr | 2.4% | Mar 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | ₹38 Cr | -14% | Jun 2026 |
| Krishna Institute of Medical Sciences Ltd KIMS | ₹33 Cr | -69% | Mar 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | ₹30 Cr | 30% | Mar 2026 |
| Shalby Ltd SHALBY⚠ unverified | ₹18 Cr | 250% | Mar 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | ₹16 Cr | 0.0% | Mar 2026 |
| KMC Speciality Hospitals (India) Ltd 524520 | ₹15 Cr | 200% | Mar 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | ₹15 Cr | 15% | Mar 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | ₹10 Cr | 100% | Jun 2026 |
| Healthcare Global Enterprises Ltd HCG | ₹4 Cr | -40% | Mar 2026 |
Full 20-quarter history · every available company
Net profit · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
Profit growth · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
Return On Capital Employed
Indraprastha Medical Corporation Ltd has the highest ROCE among the 19 Hospitals companies compared here, at 35.8%. KMC Speciality Hospitals (India) Ltd is next at 26%. KMC Speciality Hospitals (India) Ltd has the highest ROCE change at +9 percentage points, so level and change sit with different companies. Its ROCE series carries 15 reported observations across the 20-quarter window.
What the numbers say: Indraprastha Medical Corporation Ltd leads ROCE at 35.8%, 9.8 percentage points above KMC Speciality Hospitals (India) Ltd. KMC Speciality Hospitals (India) Ltd has the strongest latest improvement at +9 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: Indraprastha Medical Corporation Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
Withheld from this chart: Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — its two data sources disagree by up to 6.3% on reported income across 14 comparable periods, so its derived ratios are withheld; Fortis Healthcare Ltd (FORTIS) — its two data sources disagree by up to 12% on reported income across 14 comparable periods, so its derived ratios are withheld; Krishna Institute of Medical Sciences Ltd (KIMS) — its two data sources disagree by up to 27% on reported income across 14 comparable periods, so its derived ratios are withheld; Healthcare Global Enterprises Ltd (HCG) — its two data sources disagree by up to 95% on reported income across 14 comparable periods, so its derived ratios are withheld; Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) — its two data sources disagree by up to 4.5% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Indraprastha Medical Corporation Ltd INDRAMEDCO | 27% | −2.6 pp | Mar 2026 |
| Kovai Medical Center & Hospital Ltd KOVAI | 19% | +0.1 pp | Mar 2026 |
| Rainbow Childrens Medicare Ltd RAINBOW | 15% | −0.6 pp | Jun 2026 |
| Dr Agarwals Eye Hospital Ltd DRAGARWQ | 15% | +0.2 pp | Mar 2026 |
| GPT Healthcare Ltd GPTHEALTH⚠ unverified | 15% | −5.5 pp | Mar 2026 |
| Global Health Ltd MEDANTA | 13% | −3.3 pp | Jun 2026 |
| Sakar Healthcare Ltd SAKAR⚠ unverified | 12% | +3.8 pp | Jun 2026 |
| Max Healthcare Institute Ltd MAXHEALTH | 12% | +0.6 pp | Mar 2026 |
| Jupiter Life Line Hospitals Ltd JLHL | 12% | −2.0 pp | Jun 2026 |
| Artemis Medicare Services Ltd ARTEMISMED | 12% | +2.2 pp | Mar 2026 |
| Narayana Hrudayalaya Ltd NH | 11% | −5.4 pp | Jun 2026 |
| Aster DM Quality Care Ltd ASTERDM | 8.9% | −0.1 pp | Mar 2026 |
| Shalby Ltd SHALBY⚠ unverified | 5.8% | −0.7 pp | Mar 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Showing the 12 largest of 13 companies with a series here. The remaining 1 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Artemis Medicare Services Ltd · ARTEMISMED
Aster DM Quality Care Ltd · ASTERDM
Dr Agarwals Eye Hospital Ltd · DRAGARWQ
Global Health Ltd · MEDANTA
Indraprastha Medical Corporation Ltd · INDRAMEDCO
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Sakar Healthcare Ltd · SAKAR⚠ unverified
Shalby Ltd · SHALBY⚠ unverified
ROCE change · reported quarter history
Showing the 12 largest of 13 companies with a series here. The remaining 1 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Artemis Medicare Services Ltd · ARTEMISMED
Aster DM Quality Care Ltd · ASTERDM
Dr Agarwals Eye Hospital Ltd · DRAGARWQ
Global Health Ltd · MEDANTA
Indraprastha Medical Corporation Ltd · INDRAMEDCO
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Sakar Healthcare Ltd · SAKAR⚠ unverified
Shalby Ltd · SHALBY⚠ unverified
Valuation Against Growth & Quality
Indraprastha Medical Corporation Ltd has the lowest PEG among the 19 Hospitals companies compared here, at 0.92×. Artemis Medicare Services Ltd is next at 1.09×. The same company also holds the lowest P/E, at 18.3×. 10 of 19 companies report a comparable reading, the latest through Mar 2026. Its PEG series carries 17 reported observations across the 20-quarter window.
What the numbers say: Indraprastha Medical Corporation Ltd has the lowest comparable PEG at 0.92×, 15.6% below Artemis Medicare Services Ltd. Only 10 of 19 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
All-company data · latest reported quarter
Full 20-quarter history · every available company
PEG · reported quarter history
Artemis Medicare Services Ltd · ARTEMISMED
Aster DM Quality Care Ltd · ASTERDM
Dr Agarwals Eye Hospital Ltd · DRAGARWQ
Global Health Ltd · MEDANTA
Indraprastha Medical Corporation Ltd · INDRAMEDCO
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
P/E · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Apollo Hospitals Enterprise Ltd · APOLLOHOSP
Aster DM Quality Care Ltd · ASTERDM
Fortis Healthcare Ltd · FORTIS
Global Health Ltd · MEDANTA
Healthcare Global Enterprises Ltd · HCG
Jupiter Life Line Hospitals Ltd · JLHL
Kovai Medical Center & Hospital Ltd · KOVAI
Krishna Institute of Medical Sciences Ltd · KIMS
Max Healthcare Institute Ltd · MAXHEALTH
Narayana Hrudayalaya Ltd · NH
Rainbow Childrens Medicare Ltd · RAINBOW
Yatharth Hospital & Trauma Care Services Ltd · YATHARTH
What can make this comparison misleading?
This Hospitals comparison names 6 specific ways its own evidence can mislead, all listed below. All 19 companies here report on comparable dates, so no rank carries a stale marker. 3 draw at least one figure from a second feed with too little overlap to cross-check. 5 have second-feed figures withheld because the two sources disagree.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 3 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
- 5 companies are missing from the second-feed metrics by decision, not by absence: the two sources disagree, so nothing from the second is drawn. Read those rows as narrower evidence, never as a weaker business.
How was this comparison built?
This comparison is built from the reported filings of 19 Hospitals companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-31. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
Hospitals company comparison FAQs
These 24 answers restate the Hospitals comparison above in question form. Every one is computed from the same 19 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-31. Nothing here is estimated, and none of it is a recommendation.
Is the Hospitals sector outperforming NIFTY 500?
Hospitals has outperformed NIFTY 500 by 7.8% over 52 weeks and 10.2% over 13 weeks. 16 of 19 covered companies beat NIFTY on Mansfield relative strength, while 9 of 19 beat the sector itself.
Which Hospitals company is largest by revenue?
Apollo Hospitals Enterprise Ltd leads with revenue of ₹25,229 crore, based on 19 of 19 comparable companies through Mar 2026.
Which Hospitals company is growing fastest?
Narayana Hrudayalaya Ltd has the fastest current revenue growth at 59.6%, across 19 of 19 comparable companies.
Which Hospitals company has the strongest 4-Factor Sector Score?
KMC Speciality Hospitals (India) Ltd ranks first at 82.1/100 with 78.1% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Hospitals company has the lowest comparable PEG?
Indraprastha Medical Corporation Ltd has the lowest comparable PEG at 0.92, among 10 of 19 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Hospitals comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
What is the Nifty Hospitals index?
The Nifty Hospitals index tracks India's listed Hospitals companies as a single basket. This page follows the same 19 companies and equal-weights them, so every company's weekly return counts once whatever it is worth, and the reading belongs to the Hospitals sector rather than to its largest constituent. Figures are as of Jun 2026.
Which are the best Hospitals stocks in India?
Ranked by this page's four-factor score, KMC Speciality Hospitals (India) Ltd places first among 19 listed Hospitals companies, followed by Artemis Medicare Services Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many Hospitals stocks are listed in India?
This comparison covers 19 listed Hospitals companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which Hospitals company is the biggest?
Apollo Hospitals Enterprise Ltd is the largest, with trailing-twelve-month revenue of ₹25,229 crore, ahead of Fortis Healthcare Ltd at ₹9,128 crore. That covers 19 of 19 companies with comparable reporting through Mar 2026.
Which Hospitals company has the best profit margins?
KMC Speciality Hospitals (India) Ltd has the highest operating margin at 31%, from 19 of 19 comparable companies. KMC Speciality Hospitals (India) Ltd shows the biggest recent improvement, at +6 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Hospitals company makes the most profit?
Apollo Hospitals Enterprise Ltd earns the most, at ₹2,002 crore of trailing-twelve-month net profit, from 19 of 19 comparable companies. KMC Speciality Hospitals (India) Ltd has the fastest profit growth at 100%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Hospitals company earns the highest return on capital?
Indraprastha Medical Corporation Ltd leads on return on capital employed at 35.8%, across 19 of 19 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Hospitals stock is the cheapest?
On PEG — where a LOWER number is cheaper — Indraprastha Medical Corporation Ltd screens cheapest at 0.92×. Only 10 of 19 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Hospitals sector beating the market?
Hospitals has outperformed NIFTY 500 by 7.8% over the last 52 weeks and 10.2% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 16 of 19 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Hospitals stock has the strongest price momentum?
Sakar Healthcare Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Hospitals company scores highest for research priority?
KMC Speciality Hospitals (India) Ltd scores 82.1 out of 100 with 78.1% evidence confidence, from 30.8 points on growth and earnings, 20.6 on capital efficiency, 11.2 on valuation and 19.5 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Hospitals companies does this comparison cover, and over what period?
It compares 19 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Hospitals sector?
The 19 Hospitals companies on this page carry ₹5,60,204 crore of combined market value. Apollo Hospitals Enterprise Ltd is the largest at ₹1,28,788 crore, about 23% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-05.
What is the Hospitals sector's P/E ratio?
The median price-to-earnings ratio across the 19 Hospitals companies on this page is 54.1×, measured on the 19 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-05.
How is the Hospitals sector performing?
16 of the 19 covered Hospitals companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 7.8% ahead of NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-05.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.